These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32604407)

  • 1. Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention.
    Hall MW; Joshi I; Leal L; Ooi EE
    Clin Infect Dis; 2022 Jan; 74(1):144-148. PubMed ID: 32604407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art.
    Zhang Y; Chen Y; Meng Z
    Front Immunol; 2020; 11():577442. PubMed ID: 33240265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
    Pourgholaminejad A; Pahlavanneshan S; Basiri M
    Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection.
    Rodríguez-Argente F; Alba-Domínguez M; Ortiz-Muñoz E; Ortega-González Á
    Scand J Immunol; 2021 Jan; 93(1):e12972. PubMed ID: 32892403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation and immunotherapeutics of COVID-19.
    Garg SS; Sharma A; Gupta J
    Clin Immunol; 2021 Oct; 231():108842. PubMed ID: 34461289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions.
    Meyerowitz EA; Sen P; Schoenfeld SR; Neilan TG; Frigault MJ; Stone JH; Kim AY; Mansour MK
    Clin Infect Dis; 2021 Jun; 72(12):e1130-e1143. PubMed ID: 33216852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
    Pinheiro MM; Fabbri A; Infante M
    Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
    Zayed M; Iohara K
    Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaco-Immunomodulatory Therapy in COVID-19.
    Rizk JG; Kalantar-Zadeh K; Mehra MR; Lavie CJ; Rizk Y; Forthal DN
    Drugs; 2020 Sep; 80(13):1267-1292. PubMed ID: 32696108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage.
    Bass A; Liu Y; Dakshanamurthy S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients.
    Dulek DE; Fuhlbrigge RC; Tribble AC; Connelly JA; Loi MM; El Chebib H; Chandrakasan S; Otto WR; Diorio C; Keim G; Walkovich K; Jaggi P; Girotto JE; Yarbrough A; Behrens EM; Cron RQ; Bassiri H
    J Pediatric Infect Dis Soc; 2020 Dec; 9(6):716-737. PubMed ID: 32808988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
    Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
    Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
    Jamshidi E; Babajani A; Soltani P; Niknejad H
    Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.